51
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Benefit of the Optimized Formula of Yinxieling in Psoriasis Vulgaris via Regulation on Autophagy Based on microRNA Expression Profile and Network Pharmacology Analysis

, , , , , , , , , , , , , , & show all
Pages 2257-2272 | Received 14 Jan 2024, Accepted 26 May 2024, Published online: 13 Jun 2024

References

  • Reid C, Griffiths CEM. Psoriasis and treatment: past, present and future aspects. Acta Derm Venereol. 2020;100(3):adv00032. doi:10.2340/00015555-3386
  • Zhang P, Wu MX. A clinical review of phototherapy for psoriasis. Lasers Med Sci. 2018;33(1):173–180. doi:10.1007/s10103-017-2360-1
  • Kim WB, Jerome D, Yeung J. Diagnosis and management of psoriasis. Can Fam Physician. 2017;63(4):278–285.
  • Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397(10281):1301–1315. doi:10.1016/S0140-6736(20)32549-6
  • Yu L, Chen Y, Tooze SA. Autophagy pathway: cellular and molecular mechanisms. Autophagy. 2018;14(2):207–215. doi:10.1080/15548627.2017.1378838
  • Klionsky DJ, Petroni G, Amaravadi RK, et al. Autophagy in major human diseases. EMBO j. 2021;40(19):e108863. doi:10.15252/embj.2021108863
  • Guo Y, Zhang X, Wu T, Hu X, Su J, Chen X. Autophagy in Skin Diseases. Dermatology. 2019;235(5):380–389. doi:10.1159/000500470
  • Hailfinger S, Schulze-Osthoff K. Impaired autophagy in psoriasis and atopic dermatitis: a new therapeutic target? J Invest Dermatol. 2021;141(12):2775–2777. doi:10.1016/j.jid.2021.06.006
  • Hamaoui D, Subtil A. ATG16L1 functions in cell homeostasis beyond autophagy. Febs j. 2022;289(7):1779–1800. doi:10.1111/febs.15833
  • Hawkes JE, Nguyen GH, Fujita M, et al. microRNAs in Psoriasis. J Invest Dermatol. 2016;136(2):365–371. doi:10.1038/JID.2015.409
  • Mirzaei R, Zamani F, Hajibaba M, et al. The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases. J Neuroimmunol. 2021;358:577640. doi:10.1016/j.jneuroim.2021.577640
  • Pink RC, Samuel P, Massa D, Caley DP, Brooks SA, Carter DR. The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells. Gynecol Oncol. 2015;137(1):143–151. doi:10.1016/j.ygyno.2014.12.042
  • Zhao L, Zhou X, Shan X. Differential expression levels of plasma microRNA in Hashimoto’s disease. Gene. 2018;642:152–158. doi:10.1016/j.gene.2017.10.053
  • Lai K, Jia S, Yu S, Luo J, He Y. Genome-wide analysis of aberrantly expressed lncRNAs and miRNAs with associated co-expression and ceRNA networks in β-thalassemia and hereditary persistence of fetal hemoglobin. Oncotarget. 2017;8(30):49931–49943. doi:10.18632/oncotarget.18263
  • Bujoreanu FC, Bezman L, Radaschin DS, et al. Nevi, biologics for psoriasis and the risk for skin cancer: a real concern? Case presentation and short review. Exp Ther Med. 2021;22(6):1354. doi:10.3892/etm.2021.10789
  • Wei JA, Han L, Lu CJ, et al. Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2. BMC Complement Altern Med. 2016;16(1):255. doi:10.1186/s12906-016-1234-6
  • Han L, Sun J, Lu CJ, et al. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression. Int Immunopharmacol. 2017;44:226–233. doi:10.1016/j.intimp.2017.01.023
  • Chen SD, Lu CJ, Zhao RZ. Identification and quantitative characterization of PSORI-CM01, a Chinese medicine formula for psoriasis therapy, by liquid chromatography coupled with an LTQ Orbitrap mass spectrometer. Molecules. 2015;20(1):1594–1609. doi:10.3390/molecules20011594
  • Parker S, Zhang AL, Zhang CS. Add-on effect of PSORI-CM01 to topical calcipotriol for moderate psoriasis vulgaris: a multi-center, randomized, double-blind pilot study. Clin Transl Med. 2021;11(1):e286. doi:10.1002/ctm2.286
  • Deng J, Yao D, Lu C, et al. Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial. BMJ Open. 2017;7(11):e014475. doi:10.1136/bmjopen-2016-014475
  • Varshney P, Saini N. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5 Pt A):1795–1803. doi:10.1016/j.bbadis.2018.02.003
  • Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci. 2020;21(20):7488. doi:10.3390/ijms21207488
  • Li T, Gao S, Han W, et al. Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis. J Ethnopharmacol. 2022;294:115275. doi:10.1016/j.jep.2022.115275
  • Yao DN, Lu CJ, Wen ZH, et al. Comparison of PSORI-CM01 granules and Yinxieling tablets for patients with chronic plaque psoriasis: a pilot study for a randomized, double-blinded, double-dummy, multicentre trial. Ann Palliat Med. 2021;10(2):2036–2047. doi:10.21037/apm-20-2575
  • Shi L, Zhu W, Huang Y, et al. Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer. Clin Transl Med. 2022;12(7):e989. doi:10.1002/ctm2.989
  • Gao X, Qin T, Mao J, et al. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway. J Exp Clin Cancer Res. 2019;38(1):256. doi:10.1186/s13046-019-1260-6
  • Stoen MJ, Andersen S, Rakaee M, et al. Overexpression of miR-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer-a multi-institutional study. Cancers. 2021;13(16):4096. doi:10.3390/cancers13164096
  • Li R, Qiao M, Zhao X, Yan J, Wang X, Sun Q. MiR-20a-3p regulates TGF-β1/Survivin pathway to affect keratinocytes proliferation and apoptosis by targeting SFMBT1 in vitro. Cell Signal. 2018;49:95–104. doi:10.1016/j.cellsig.2018.06.003
  • Xu H, Li M, Pan Z, et al. miR-3184-3p enriched in cerebrospinal fluid exosomes contributes to progression of glioma and promotes M2-like macrophage polarization. Cancer Sci. 2022;113(8):2668–2680. doi:10.1111/cas.15372
  • Shang Y, Wang L, Zhu Z, et al. Downregulation of miR-423-5p Contributes to the Radioresistance in Colorectal Cancer Cells. Front Oncol. 2020;10:582239. doi:10.3389/fonc.2020.582239
  • Liu M, Shan G, Jiang H, et al. Identification of miRNA and their regulatory effects induced by total flavonoids from dracocephalum moldavica in the treatment of vascular dementia. Front Pharmacol. 2021;12:796628. doi:10.3389/fphar.2021.796628
  • Lu Y, Qi Y, Yan Y, et al. Analysis of microRNA expression in peripheral blood monocytes of three Traditional Chinese Medicine (TCM) syndrome types in psoriasis patients. Chin Med. 2020;15(1):39. doi:10.1186/s13020-020-00308-y
  • Camela E, Potestio L, Fabbrocini G, Pallotta S, Megna M. The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs. Expert Opin Investig Drugs. 2023;32(6):537–552. doi:10.1080/13543784.2023.2219387
  • Camela E, Potestio L, Fabbrocini G, Ruggiero A, Megna M. New frontiers in personalized medicine in psoriasis. Expert Opin Biol Ther. 2022;22(12):1431–1433. doi:10.1080/14712598.2022.2113872
  • Zheng X, Li W, Xu H, et al. Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway. Acta Pharm Sin B. 2021;11(11):3465–3480. doi:10.1016/j.apsb.2021.05.027
  • Zhou J, Li XY, Liu YJ, et al. Full-coverage regulations of autophagy by ROS: from induction to maturation. Autophagy. 2022;18(6):1240–1255. doi:10.1080/15548627.2021.1984656